Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 28, 2021 - Issue 3
248
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Absolute quantitative analysis of cardiac amyloidosis using SPECT/CT with 99mTc-pyrophosphate

, , , , , , , , , & show all
Pages 213-214 | Received 05 Dec 2020, Accepted 11 Mar 2021, Published online: 07 Apr 2021

References

  • Ross JC, Hutt DF, Burniston M, et al. Quantitation of (99m)Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis. Amyloid. 2018;25(3):203–210.
  • Wollenweber T, Rettl R, Kretschmer-Chott E, et al. In vivo quantification of myocardial amyloid deposits in patients with suspected transthyretin-related amyloidosis (ATTR). JCM. 2020;9(11):3446.
  • Scully PR, Morris E, Patel KP, et al. DPD quantification in cardiac amyloidosis: a novel Imaging biomarker. JACC Cardiovasc Imaging. 2020;13(6):1353–1363.
  • Caobelli F, Braun M, Haaf P, et al. Quantitative 99mTc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: feasibility and correlation with visual scores. J Nucl Cardiol. 2020;27(5):1456–1463.
  • Bellevre D, Bailliez A, Delelis F, et al. Quantitation of myocardial (99m)Tc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use? J Nucl Cardiol. 2020 [Epub ahead of print]. DOI:10.1007/s12350-020-02274-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.